Frequently Asked Questions

How do healthcare consultation pathways operate in Australia?

Healthcare practitioners may access medicinal cannabis pathways through established Australian regulatory systems, including:

• 1. Special Access Scheme (SAS)

  2. Authorised Prescriber pathways

Independent healthcare practitioners assess each patient individually according to:

• • healthcare history

  • current medications

  • previous healthcare approaches

  • broader healthcare considerations

  • ongoing healthcare circumstances

  • clinical judgement

Access pathways remain subject to practitioner assessment, clinical judgement, and Australian regulatory requirements.

Are telehealth consultations available?

Yes. MOCA Health supports practitioner-led telehealth consultation pathways operating throughout metropolitan, regional, and remote Australian communities.

Telehealth systems may support:

• • practitioner consultations

  • healthcare communication

  • patient intake and assessment

  • healthcare coordination pathways

  • follow-up consultation processes where appropriate

Educational resources discussing telehealth consultation pathways continue supporting broader healthcare literacy surrounding practitioner-led healthcare systems.

Are face-to-face consultations available?

MOCA Health currently operates primarily through telehealth consultation systems.

Consultation availability and healthcare delivery models may change over time according to practitioner availability, healthcare operations, and broader healthcare considerations.

Educational resources discussing telehealth consultation pathways continue supporting broader healthcare literacy surrounding practitioner-led healthcare systems.

What healthcare circumstances may practitioners assess?

Healthcare practitioners may assess patients experiencing a broad range of healthcare circumstances according to individual healthcare needs and practitioner assessment.

Assessment pathways may consider:

• • healthcare history

  • current medications

  • previous healthcare approaches

  • broader healthcare considerations

  • ongoing healthcare circumstances

All prescribing decisions remain subject to practitioner assessment, clinical judgement, and Australian regulatory requirements.

Consultations do not guarantee prescriptions, approvals, or treatment outcomes.

What formulation pathways may practitioners discuss?

Within regulated healthcare environments, practitioners may discuss a range of formulation pathways depending on individual healthcare circumstances and practitioner assessment.

Educational discussions may include:

• • oil formulations

  • capsule pathways

  • vaporisation-oriented botanical formulations

  • sprays and other administration formats

Pharmacy dispensing pathways operate separately through licensed Australian pharmacies operating within regulated healthcare systems.

What are cannabinoids?

Cannabinoids are naturally occurring compounds discussed within broader healthcare and scientific research environments.

Educational healthcare resources may discuss:

• cannabinoid science

• CBD-related healthcare education

• broader cannabinoid research

• the endocannabinoid system

• botanical healthcare communication frameworks

Patients and healthcare professionals seeking broader educational information regarding cannabinoid science may also explore research-oriented healthcare information.

Are there potential healthcare considerations?

Healthcare practitioners assess healthcare considerations individually according to patient-specific healthcare circumstances and broader clinical assessment.

Educational discussions surrounding medicinal cannabis may include broader healthcare considerations relating to:

• • dizziness

  • drowsiness

  • concentration

  • balance

  • memory and cognition

Patients should discuss healthcare considerations, medications, and ongoing monitoring directly with qualified healthcare practitioners.

How much do consultations cost?

Consultation fees may vary according to:

• • practitioner requirements

  • consultation duration

  • healthcare administration processes

  • follow-up consultation pathways

Patients seeking additional information regarding consultation costs and administrative processes may contact the clinic directly for current consultation information.

How do pharmacy coordination pathways operate?

Where clinically appropriate, healthcare practitioners may independently consider prescribing pathways operating within Australian healthcare systems.

Pharmacy dispensing and healthcare coordination pathways operate separately within regulated healthcare environments involving:

• • healthcare practitioners

  • licensed pharmacies

  • telehealth consultation systems

  • healthcare communication pathways

Patients seeking broader educational information regarding pharmacy and healthcare coordination pathways can better understand how regulated medicinal cannabis systems operate throughout Australia.

Important Information

This website provides general educational information only and does not constitute medical advice.

Medicinal cannabis access pathways remain subject to practitioner assessment, clinical judgement, and Australian regulatory requirements.

No therapeutic claims are made regarding the effectiveness or suitability of any healthcare pathway, formulation, or treatment approach.

Individual healthcare experiences and healthcare pathways may vary.